INQOVI FDA approval date

The FDA approved INQOVI on 7 Jul 2020.

FDA approval date
7 Jul 2020

Drug identity has not yet been verified against registry records

Also recorded as CEDAZURIDINE; DECITABINE

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2020-07-07DayINQOVIFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA212576", "applicant_as_listed_by_fda": "TAIHO ONCOLOGY", "brand_names": ["INQOVI"], "active_ingredients": ["CEDAZURIDINE", "DECITABINE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20200707", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026